LRMR

Larimar Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.13

-0.07 (-2.19%)

Rating:C+

CEO

Carole S. Ben-Maimon

IPO Date

2014-06-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$3.12

Prev. Close

$3.20

Day Low

$3.10

Day High

$3.21

52W Low

$2.71

52W High

$6.42

Market Cap

$0.27B

Volume

0.38M

News SentimentBullish

Articles

Avg Positive

38.8%

Avg Negative

21.2%

Avg Neutral

40.1%

News Feed

Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR

Larimar Therapeutics Reports FDA Clinical Hold on CTI-1601 and Termination of Recently Announced Private Placement Financing